Market Place
Sourcing Support
All News #Library
Biotech
CNS Pharma Unveils Strategy For High-Value Neurology & Oncology
11 Mar 2026 //
PHARMIWEB
CNS Pharmaceuticals Announces CEO Transition
17 Dec 2025 //
PHARMIWEB
CNS Pharma to Present Three Abstracts at SNO 30th Annual Meeting
10 Nov 2025 //
PHARMIWEB
CNS Pharma To Participate In Webull Corporate Connect Biotech Webinar
27 Aug 2024 //
ACCESSWIRE
CNS Announces Efficacy and Safety Data in Potentially Pivotal Study of Berubicin
18 Dec 2023 //
ACCESSWIRE
CNS Achieves Over 50% Completion of Enrollment in Study with Berubicin for GBM
25 May 2023 //
ACCESSWIRE
Patients Enrolled in CNS Pharmac’ Pivotal Study Evaluating Berubicin
10 Apr 2023 //
ACCESSWIRE
CNS Pharmaceuticals Receives Approval for Berubicin for the Treatment of GBM
06 Apr 2023 //
ACCESSWIRE
CNS Continues Momentum in Potentially Pivotal Global Trial Evaluating Berubicin
09 Mar 2023 //
PR NEWSWIRE
CNS Announces First Patient Enrolled in Spain in Trial Evaluating Berubicin
07 Feb 2023 //
PR NEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.